NCT04083170 2025-01-01
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
Fred Hutchinson Cancer Center
Phase 2 Terminated
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)